Menu Close

Trending

AbbVie and Cugene partner to tackle autoimmune diseases
2nd Annual mRNA-Based Therapeutics Summit
BenevolentAI, AstraZeneca AI-based drug discovery collaboration achieves third milestone
Do pharmaceutical businesses need to rethink what their graduate schemes offer?
AstraZeneca extends oncology partnership with Proteros

PCSK9 inhibitors

AstraZeneca (AZ)

News/ News/ R&D/ Top stories

AZ buys oral PCSK9 cholesterol drug from Dogma Therapeutics

, , , , , 0 Comment

AstraZeneca has bought rights to an orally-active drug that inhibits PCSK9, offering a patient-friendly alternative to current cholesterol-lowering

X
AZ buys oral PCSK9 cholesterol drug from Dogma Therapeutics
https://pharmaphorum.com/news/az-buys-oral-pcsk9-cholesterol-drug-from-dogma-therapeutics/
Stethescope heart

News/ News/ R&D

TMC’s inclisiran impresses at ESC, but will it surpass PCSK9 rivals?

, , , , , , , , , , , 0 Comment

Cardiologists only had to wait a few days after The Medicines Company teased top-line results with its cholesterol-lowering

X
TMC’s inclisiran impresses at ESC, but will it surpass PCSK9 rivals?
https://pharmaphorum.com/news/tmcs-inclisiran-impresses-at-esc-but-will-it-surpass-pcsk9-rivals/

Login

CONTINUE TO SITE >
X
Close in 10 seconds